Page mentions trial results of vaccine candidates from GSK (protein subunit with adjuvant), J&J (viral vector), and Pfizer (protein subunit with adjuvant).
RSV is a respiratory virus that is most dangerous to infants and elderly people.
5 Likes
JNJ stopped all the development for their RSV vaccine a week or two ago. But the GSK and Pfizer products look strong and will be welcome for many.
1 Like
Thank goodness. RSV is pretty awful.
1 Like
That’s great news. My middle child was hospitalized for five days with RSV when he was nine weeks old. I had never heard of it before! He was on oxygen and it was scary. 